Milton J. Finegold

Biochemistry, Genetics and Molecular Biology · Life Sciences

104h-index45.8kcitations504works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(57), Pediatric Hepatobiliary Diseases and Treatments(51), Liver physiology and pathology(42), Liver Disease Diagnosis and Treatment(40), Metabolism and Genetic Disorders(39)

Publications502 total

Asynchronous Transitions from High-Risk Hepatoblastoma to Carcinoma
Journal of Hepatology·2026Open Access
Author response: Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
2025Open Access
Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
eLife·2025Open Access
Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
2025Open Access
Author response: Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
2025Open Access
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma
Annals of Surgery·2025
Author response: Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
2025Open Access
Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
2025Open Access
Asynchronous Transitions from High-Risk Hepatoblastoma to Carcinoma
2024· 1 citedOpen Access
Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
2024· 4 citedOpen Access
Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females
eLife·2024Open Access
Long‐term combination therapy with metformin and oxymetholone in a Fanconi anemia mouse model
Pediatric Blood & Cancer·2024· 2 cited
Long-term combination therapy with Metformin and Oxymetholone in a Fanconi Anemia mouse model
2023Open Access
Vincristine/irinotecan/temsirolimus upfront window treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee
Pediatric Blood & Cancer·2023· 9 citedOpen Access
Data from <i>Growth Factor–Independent 1</i> Is a Tumor Suppressor Gene in Colorectal Cancer
2023Open Access
Supplementary Figures S1 - S4 from <i>Growth Factor–Independent 1</i> Is a Tumor Suppressor Gene in Colorectal Cancer
2023Open Access
Supplementary Figures S1 - S4 from <i>Growth Factor–Independent 1</i> Is a Tumor Suppressor Gene in Colorectal Cancer
2023Open Access
Data from <i>Growth Factor–Independent 1</i> Is a Tumor Suppressor Gene in Colorectal Cancer
2023Open Access
Supplementary Figure Legends from β-Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma
2023Open Access
Supplementary Figure 3 from β-Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma
2023Open Access
page 1 of 26Next →

Frequent Co-authors

Markus Grompe(15), Muhsen Al-Dhalimy(8), Mark A. Kay(5), Eric Lagasse(4), Xin Wang(4), Craig Dorrell(4), Francesco J. DeMayo(4), Allan Bradley(4), Martin M. Matzuk(4), Frances E. Leland(4), Savio L.C. Woo(4), Mark P. Foster(3), Susan B. Olson(3), Jeffrey M. Rosen(3), Dolores López‐Terrada(3), Holger Willenbring(2), Yassmine Akkari(2), Norman M. Greenberg(2), Robert J. Matusik(2), Margaret Wilde(2)